Explore

Trendline Trendline
AI-Designed Miniprotein Switches Offer New Approach to GPCR Targeting

AI-Designed Miniprotein Switches Offer New Approach to GPCR Targeting

AI-Designed Miniprotein Switches Offer New Approach to GPCR Targeting
Trendline Trendline
Skape Bio Unveils AI-Driven Platform for GPCR Biotherapeutics, Promising New Drug Development Pathways

Skape Bio Unveils AI-Driven Platform for GPCR Biotherapeutics, Promising New Drug Development Pathways

Skape Bio Unveils AI-Driven Platform for GPCR Biotherapeutics, Promising New Drug Development Pathways
Trendline Trendline
Genethon and Ampersand Biomedicines Partner to Enhance Gene Therapy Precision

Genethon and Ampersand Biomedicines Partner to Enhance Gene Therapy Precision

Genethon and Ampersand Biomedicines Partner to Enhance Gene Therapy Precision
Trendline Trendline
Rancho BioSciences Launches OmicsHQ to Accelerate Drug Discovery with Curated Multi-Omics Data

Rancho BioSciences Launches OmicsHQ to Accelerate Drug Discovery with Curated Multi-Omics Data

Rancho BioSciences Launches OmicsHQ to Accelerate Drug Discovery with Curated Multi-Omics Data
Trendline Trendline
OpenBind Consortium Launches AI Model to Revolutionize Drug Discovery

OpenBind Consortium Launches AI Model to Revolutionize Drug Discovery

OpenBind Consortium Launches AI Model to Revolutionize Drug Discovery
Trendline Trendline
OpenBind Launches AI Model for Drug Discovery with Extensive Dataset

OpenBind Launches AI Model for Drug Discovery with Extensive Dataset

OpenBind Launches AI Model for Drug Discovery with Extensive Dataset
Trendline Trendline
OpenBind Introduces AI Model to Revolutionize Drug Discovery

OpenBind Introduces AI Model to Revolutionize Drug Discovery

OpenBind Introduces AI Model to Revolutionize Drug Discovery
Trendline Trendline
Rancho BioSciences Launches OmicsHQ to Accelerate Drug Discovery

Rancho BioSciences Launches OmicsHQ to Accelerate Drug Discovery

Rancho BioSciences Launches OmicsHQ to Accelerate Drug Discovery
Trendline Trendline
Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering with Quantum Physics and AI

Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering with Quantum Physics and AI

Imperagen Secures $6.7 Million to Revolutionize Enzyme Engineering with Quantum Physics and AI
Trendline Trendline
Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform

Passkey Therapeutics Appoints New CMO to Advance Drug Combination Platform
Trendline Trendline
Thermo Fisher Scientific Showcases Growth Strategy and AI Integration at 2026 Investor Day

Thermo Fisher Scientific Showcases Growth Strategy and AI Integration at 2026 Investor Day

Thermo Fisher Scientific Showcases Growth Strategy and AI Integration at 2026 Investor Day
Trendline Trendline
Araceli Biosciences Unveils Endeavor Live Cell for Enhanced AI-Driven Drug Discovery

Araceli Biosciences Unveils Endeavor Live Cell for Enhanced AI-Driven Drug Discovery

Araceli Biosciences Unveils Endeavor Live Cell for Enhanced AI-Driven Drug Discovery